Bundibugyo 100 Days Response: $185m Funding Gap Threatens Vaccine Access – CEPI

100 days into the global response to the Bundibugyo ebolavirus emergency, the Coalition for Epidemic Preparedness Innovations (CEPI) has raised a clear alarm. A massive $185 million funding deficit is currently threatening global access to life-saving vaccines.

The Africa Centres for Disease Control and Prevention (Africa CDC) alongside the World Health Organization (WHO) created a joint Continental Preparedness and Response Plan with a budget of $518 million. However, official records from CEPI show that donors have disbursed only $333.2 million so far. This leaves a severe $184.8 million shortfall that puts human lives directly at risk.

The 100 Days Mission aims to develop and roll out safe treatments rapidly during public health emergencies. Scientists made history by moving candidate vaccines into Phase 1 clinical trials in under 11 weeks. Yet, without immediate financial backing, Phase 2 and Phase 3 trials cannot proceed smoothly.

Without immediate cash injection, vaccine production lines will freeze. That means vulnerable communities and frontline health workers in affected African regions will simply not get early protection.

Failing to plug this funding hole does not just delay medical research; it actively costs human lives. CEPI is targeting Emergency Use Authorisation for at least two vaccine candidates to bring this outbreak under control.

Beyond money, health organizations face the challenge of building community trust and ensuring fair distribution for displaced groups. World leaders must honor their financial pledges right now before this preventable gap becomes a full-blown global tragedy.

Also Read: west african stakeholders support technology driven malaria control a